U.S. markets closed

ImmunityBio, Inc. (IBRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.00-0.67 (-6.28%)
At close: 4:00PM EDT
10.18 ++0.18 (+1.80%)
After hours: 07:57PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close10.67
Open10.50
Bid9.91 x 800
Ask10.01 x 1400
Day's Range9.94 - 10.69
52 Week Range6.80 - 45.42
Volume750,421
Avg. Volume840,150
Market Cap3.912B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.61
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est25.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ImmunityBio, Inc.
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
    Rating
    Fair Value
    Economic Moat
    12 days agoMorningstar
View more